In our study, co-incubation of TNF-α and IL-2 can produce a significant increase in Tregs over IL-2 alone in ND AML patients (P < 0.01), and the usage of anti-TNFR2 antibody would eliminate such effect. This evidence concerns the gene TNF and acute myeloid leukemia.